See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Gennadi Kobzar

https://www.etis.ee/CV/Gennadi_Kobzar/est
19.11.1950
6204380
gennadi.kobzar@ttu.ee

Teenistuskäik

Töökohad ja ametid
1986-2002. a. Eesti TA ja TTÜ Keemia Instituudi, vanemteadur;
1985-1986 Eesti TM Eksperimentaalse ja Kliinilise Meditsiini Instituudi vanemteadur ja 1981-1985. a. nooremteadur;
1977-1981. a. NSVL TA Merebioloogia Instituudi nooremteadur
01.01.2017–31.12.2019   
Tallinna Tehnikaülikool, Loodusteaduskond, Keemia ja biotehnoloogia instituut, Vanemteadur (1,00)
01.09.2002–31.12.2016   
Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Keemiainstituut, Vanemteadur (1,00)
 
 
Haridustee
1979. a. lõpetasin NSVL TA Setšenovi nim. Evolutsioonilise Füsioloogia ja Biokeemia Instituudi (Leningrad) aspirantuuri;
1973. a. lõpetasin Kaliningradi Riikliku Ülikooli bioloogia erialal;
1968. a. lõpetasin Keila Keskkooli.
 
 
Lisainfo
Alates 2003.a. pean Matemaatika-loodusteaduskonna meditsiinilise keemia loenguid.
Saskia Sonberg, bakalaureusetöö, 2013, (juh)Gennadi Kobzar. Lämmastikosiidi doonorite toime vereliistakutele. Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Keemiainstituut, Bioorgaanilise keemia õppetool.

Kvalifikatsioon

Teaduskraadid
Gennadi Kobzar, doktorikraad, 1979, (juh) Ella Zeimal, Molluski Planorbarius corneus identifitseeritud neuronite atsetüülkoliini retseptorid ja postsünaptilisi potentsiaale esilekutsuv ülekandeaine., NSVL TA Setšenovi nim. Evolutsioonilise Füsioloogia ja Biokeemia Instituut (Leningrad).
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.1. Biokeemia
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.1. Biokeemia; TÄPSUSTUS: Bioaktiivsete ainete toime uurimine elusrakkude funktsioonidele ja rakusisestele biokeemilistele protsessidele
 
 
Lisainfo
Kandidaadikraad. NSVL TA Setšenovi nim. Evolutsioonilise Füsioloogia ja Biokeemia Instituut (Leningrad), 1979.a.

Lõppenud projektid

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2020
Kobzar, G. (2020). Inhibition of platelet activation using vitamins. Platelets, 31 (2), 157−166.10.1080/09537104.2019.1652262.
1.1.
2017
Kobzar, G.; Mardla, V.; Samel. N. (2017). Glucose impairs aspirin inhibition in platelets through a NAD(P)H oxidase signaling pathway. Prostaglandins & Other Lipid Mediators, 131, 33−40. DOI: 10.1016/j.prostaglandins.2017.07.004.
5.2.
2016
Kobzar, G.; Mardla, V.; Samel, N. (2016). Glucose activates NOX signalling pathway in platelets. Primary Care Diabetes, 10. Elsevier, e5. (Supplement 1). DOI: 10.1016/j.pcd.2016.08.017.
1.1.
2014
Kobzar, G.; Mardla, V.; Samel, N. (2014). Lactate is a possible mediator of the glucose effect on platelet inhibition. Platelets, 25 (4), 239−245. DOI: 10.3109/09537104.2013.816670.
1.3.
2014
Mardla, V.; Rooks, E.; Kobzar, G.; Samel, N.. (2014). Glükoosi pidurdav toime trombotsüütide agregatsiooni inhibeerimisele COXi inhibiitorite ja L-arginiiniga in vitro. Eesti Arst, 93 (5), 263−267.
5.2.
2012
Kobzar, G.; Mardla, V.; Samel, N. (2012). Glucose prevents inhibition of platelets caused by NOS activation. 1st EUPLAN Platelet Conference, Maastricht The Netherlands, September 19-21th 2012. , 108.
1.1.
2011
Kobzar, G.; Mardla, V.; Samel, N. (2011). Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors. Platelets, 22, 338−344.
1.3.
2010
Mardla, V.; Rätsep, I.; Kobzar, G.; Samel, N. (2010). COX inhibiitorite nimesuliidi, paratsetamooli ja metamisooli toime aspiriinresistentsete koronaarhaigete trombotsüütidele enne ja pärast aortokoronaarset šunteerimist. Eesti Arst, 89, 470−476.
5.2.
2010
Kobzar, G.; Mardla, V.; Samel, N. (2010). Interaction of glucose with inhibitors of cyclooxygenase in platelets (Abstracts presented at the Nottingham Platelet Conference, Platelets - Past, Present and Future). Platelets, 21 (5), 407.
1.1.
2009
Kobzar, G.; Mardla, V.; Rätsep, I.; Samel, N. (2009). Effect of vitamin B6 vitamers on platelet aggregation. Platelets, 20 (2), 120−124.
2.2.
2009
Mardla, V.; Kobzar, G. (2009). Inhibition of platelets with combination of natural agents : Synergistic effects of antiaggregants. Köln: Lambert Academic Publishing.
5.2.
2009
Kobzar, G.; Mardla, V. (2009). Inhibition of platelet aggregation by vitamin B6. Annals of Nutrition and Metabolism, 55, 408.
1.3.
2008
Mardla, V.; Rätsep, I.; Kobzar, G.; Špitsmeister, M.; Samel, N. (2008). Trombotsüütide agregatsiooni inhibeerimine B6-vitamini vitameeridega in vitro koronaarhaigetel. Eesti Arst, 87 (12), 923−929.
1.1.
2006
Kobzar, G.; Mardla, V; Ratsep, I; Samel, N. (2006). Platelet activity before and after coronary artery bypass grafting. Platelets, 17, 289−291.
1.1.
2005
Kobzar, G.; Mardla, V.; Samel, N (2005). Effects of alpha-tocopherol, L-arginine, and quercetin on aggregation of human platelets. Nutrition Research, 25 (6), 569−575.
1.2.
2005
Kobzar, G.; Mardla, V.; Samel, N. (2005). Increase in antiplatelet effects of prostaglandins by α-tocopherol and quercetin. Proceedings of the Estonian Academy of Sciences. Biology. Ecology, 54 (2), 120−125.
1.1.
2004
Mardla, V.; Kobzar, G.; Samel, N (2004). Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin. Platelets, 15 (5), 319−324.
5.2.
2004
Kobzar, G.; Mardla, V.; Samel, N. (2004). Combined effect of prostaglandins with alpha-tocopherol and quercetin. Platelets, 15 (8), 496.
5.2.
2003
Kobzar, G.; Mardla, V.; Rätsep, I.; Samel, N. (2003). Comparison of platelet aggregation in venous and arterial blood. Journal of Thrombosis and Haemostasis, 1, CD077.
1.1.
2002
Kobzar, G.; Mardla, V (2002). Inhibition of platelet aggregation by pyridoxine. Nutrition Research, 22 (9), 997−1001.
5.2.
2002
Kobzar, G.; Mardla, V.; Rätsep, I.; Raukas, R.; Samel, N. (2002). Inhibition of platelet aggregation by alpha-tocopherol in healthy subjects and patients with coronary artery disease. Platelets, 13 (Abstracts of Papers Presented at the Nottingham Pl), 343.
1.1.
2001
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N (2001). Comparison of anti-aggregatory effects of PGI(2), PGI(3) and iloprost on human and rabbit platelets. Cellular Physiology and Biochemistry, 11 (5), 279−284.
1.2.
2001
Mardla, V.; Kobzar, G.; Rätsep, I.; Lõhmus, M.; Järving, I.; Samel, N. (2001). Sensitivity of platelets to prostaglandins in patients with coronary artery disease. Proceedings of the Estonian Academy of Sciences. Biology. Ecology, 50 (1), 33−36.
1.1.
1999
Kobzar, G.; Mardla, V.; Ratsep, I (1999). Aspirin increases platelet sensitivity to adenosine diphosphate in patients with coronary artery disease. Platelets, 10, 191−192.
1.2.
1999
Kobzar, G.i; Mardla, V.; Rätsep, I. (1999). Sensitivity of platelets to PAF in patients with coronary artery disease. Medical & Biological Engineering & Computing, 37 (1), 242−243.
1.2.
1999
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N. (1999). Blood plasma antiaggregatory potency of prostaglandins: effects of albumin. Inflammopharmacology, 7 (2), 179−185.
5.2.
1998
Kobzar, G.; Mardla, V. (1998). Homocycline effects on platelets. Platelets, 9 (6), 413. DOI: 10.1080/09537109876483.
1.1.
1997
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N.; Lõhmus, M. (1997). Modulatory effect of 8-iso PGE2 on platelets. General Pharmacology, 28, 317−321.
1.1.
1995
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N.; Lõhmus, M. (1995). Effects of 8-iso-PGE2 on platelets and smooth muscles. , 1995, 76, Supplement III, 34. Pharmacology & Toxicology, 76, 34−34.
1.1.
1995
Kobzar, G.; Mardla, V.; Kanger, T.; Lopp, M.; Lille, Ü. (1995). Comparison of the anti-aggregatory activity of enantiomers of a 15-nonstereogenic carbacyclin analogue MM706. Pharmacology & Toxicology, 76, 297−298.
1.1.
1994
Kobzar, Gennadi; Shelkovnikov, Stanislav; Mardla, Vilja; Savitski, Gennadi; Lopp, Margus; Kanger, Tõnis; Lille, Ülo (1994). A 15-nonstereogenic carbocyclic analogue of prostacyclin : effects on human platelets and uterine artery. Journal of lipid mediators and cell signalling, 243−249.
1.1.
1993
Kobzar, G.; Mardla, V.; Järving, I.; Lõhmus, M; Vahemets, A.; Samel, N.; Lille, Ü. (1993). Comparison of the inhibitory effect of E-prostaglandins in human and rabbit platelet-rich plasma and washed platelets. ., 1993, 106C, 489-494. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 106 (2), 489−494. DOI: 10.1016/0742-8413(93)90168-K.
1.1.
1992
Kanger, T.; Lopp, M.; Müraus A., Lõhmus, M.; Kobzar, G.; Pehk, T.; Lille, Ü. (1992). Synthesis of a novel optically active 15-nonstereogenic carbaprostacyclin. Synthesis, 10, 925−927.
1.1.
1992
Lopp, M.; Kobzar, G.; Bergmann, N.; Pehk, T.; Lopp, A.; Valimae, T.; Viigimaa, M.; Lille, U. (1992). Synthesis and antiaggregative activity of novel omega-achiral carba-analogs of prostacyclin. European Journal of Medicinal Chemistry, 27 (2), 155−159.
1.2.
1987
Samel, N.; Järving, I.; Lõhmus, M.; Lopp, A.; Kobzar, G.; Sadovskaya, V.; Välimäe, T.; Lille, Ü. . (1987). Identification and biological activity of a novel natural prostaglandin, 5,6-dihydro-prostaglandin-E3. Prostaglandins, 33 (1), 137−149. DOI: 10.1016/0090-6980(87)90311-X.
20.04.2020

Gennadi Kobzar

https://www.etis.ee/CV/Gennadi_Kobzar/eng
19.11.1950
6204380
gennadi.kobzar@ttu.ee

Career

Institutions and positions
1986-2002, senior researcher at Institute of Chemistry, Tallinn Technical University;
1985-1986, senior researcher and 1981-1985 junior researcher at the Institute of Experimental and Clinical Medicine, Ministry of Health of Estonia;
1977-1981, junior researcher at the Institute of Sea Biology, Academy of Sciences of the USSR.
01.01.2017–31.12.2019   
Tallinn University of Technology , School of Science, Department of Chemistry and Biotechnology, Senior Researcher (1,00)
01.09.2002–31.12.2016   
Tallinn University of Technology , Faculty of Science, Department of Chemistry, Senior Researcher (1,00)
 
 
Education
1973-1977, post-graduate study at the Sechenov Institute of Evolutionary Physiology and Biochemistry, Academy of Sciences of the USSR;
1968-1973, Kaliningrad University, Department of Biology;
1957-1968, Keila Secondary School.
 
 
Additional information
Since 2003, I read the lectures on medical chemistry forthe students of the Faculty of Sciience since 2003.
Saskia Sonberg, Bachelor's thesis, 2013, (sup)Gennadi Kobzar. The Effect of nitric oxide donors on platelets. Tallinn University of Technology, Faculty of Scinces, Department of Chemistry, Chair of bioorganic chemistry.

Qualifications

Academic degrees
Gennadi Kobzar, Doctor's Degree, 1979, (sup) Ella Zeimal, Molluski Planorbarius corneus identifitseeritud neuronite atsetüülkoliini retseptorid ja postsünaptilisi potentsiaale esilekutsuv ülekandeaine. (The study of acetylcholine receptors and transmitter nature of postsynanaptic potentials in identified neurons of gastropod mollusc Planorbarius corneus), NSVL TA Setšenovi nim. Evolutsioonilise Füsioloogia ja Biokeemia Instituut (Leningrad).
 
 
Fields of research
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.1. Biochemistry
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.1. Biochemistry
 
 
Additional information
Ph.D.
Sechenov Institute of Evolutionary Physiology and Biochemistry, Academy of Sciences of the USSR, Leningrad, 1979.

Completed projects

Supervised dissertations

Publications

Category
Year
Publication
 
1.1.
2020
Kobzar, G. (2020). Inhibition of platelet activation using vitamins. Platelets, 31 (2), 157−166.10.1080/09537104.2019.1652262.
1.1.
2017
Kobzar, G.; Mardla, V.; Samel. N. (2017). Glucose impairs aspirin inhibition in platelets through a NAD(P)H oxidase signaling pathway. Prostaglandins & Other Lipid Mediators, 131, 33−40. DOI: 10.1016/j.prostaglandins.2017.07.004.
5.2.
2016
Kobzar, G.; Mardla, V.; Samel, N. (2016). Glucose activates NOX signalling pathway in platelets. Primary Care Diabetes, 10. Elsevier, e5. (Supplement 1). DOI: 10.1016/j.pcd.2016.08.017.
1.1.
2014
Kobzar, G.; Mardla, V.; Samel, N. (2014). Lactate is a possible mediator of the glucose effect on platelet inhibition. Platelets, 25 (4), 239−245. DOI: 10.3109/09537104.2013.816670.
1.3.
2014
Mardla, V.; Rooks, E.; Kobzar, G.; Samel, N.. (2014). Glükoosi pidurdav toime trombotsüütide agregatsiooni inhibeerimisele COXi inhibiitorite ja L-arginiiniga in vitro [Glucose impairs inhibition of platelet aggregation by COX inhibitors and L-arginine.]. Eesti Arst, 93 (5), 263−267.
5.2.
2012
Kobzar, G.; Mardla, V.; Samel, N. (2012). Glucose prevents inhibition of platelets caused by NOS activation. 1st EUPLAN Platelet Conference, Maastricht The Netherlands, September 19-21th 2012. , 108.
1.1.
2011
Kobzar, G.; Mardla, V.; Samel, N. (2011). Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors. Platelets, 22, 338−344.
1.3.
2010
Mardla, V.; Rätsep, I.; Kobzar, G.; Samel, N. (2010). COX inhibiitorite nimesuliidi, paratsetamooli ja metamisooli toime aspiriinresistentsete koronaarhaigete trombotsüütidele enne ja pärast aortokoronaarset šunteerimist. Eesti Arst, 89, 470−476.
5.2.
2010
Kobzar, G.; Mardla, V.; Samel, N. (2010). Interaction of glucose with inhibitors of cyclooxygenase in platelets (Abstracts presented at the Nottingham Platelet Conference, Platelets - Past, Present and Future). Platelets, 21 (5), 407.
1.1.
2009
Kobzar, G.; Mardla, V.; Rätsep, I.; Samel, N. (2009). Effect of vitamin B6 vitamers on platelet aggregation. Platelets, 20 (2), 120−124.
2.2.
2009
Mardla, V.; Kobzar, G. (2009). Inhibition of platelets with combination of natural agents : Synergistic effects of antiaggregants. Köln: Lambert Academic Publishing.
5.2.
2009
Kobzar, G.; Mardla, V. (2009). Inhibition of platelet aggregation by vitamin B6. Annals of Nutrition and Metabolism, 55, 408.
1.3.
2008
Mardla, V.; Rätsep, I.; Kobzar, G.; Špitsmeister, M.; Samel, N. (2008). Trombotsüütide agregatsiooni inhibeerimine B6-vitamini vitameeridega in vitro koronaarhaigetel [Inhibition of platelet aggregation by vitamin B6 vitamers in vitro in patients with coronary artery disease]. Eesti Arst, 87 (12), 923−929.
1.1.
2006
Kobzar, G.; Mardla, V; Ratsep, I; Samel, N. (2006). Platelet activity before and after coronary artery bypass grafting. Platelets, 17, 289−291.
1.1.
2005
Kobzar, G.; Mardla, V.; Samel, N (2005). Effects of alpha-tocopherol, L-arginine, and quercetin on aggregation of human platelets. Nutrition Research, 25 (6), 569−575.
1.2.
2005
Kobzar, G.; Mardla, V.; Samel, N. (2005). Increase in antiplatelet effects of prostaglandins by α-tocopherol and quercetin. Proceedings of the Estonian Academy of Sciences. Biology. Ecology, 54 (2), 120−125.
1.1.
2004
Mardla, V.; Kobzar, G.; Samel, N (2004). Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin. Platelets, 15 (5), 319−324.
5.2.
2004
Kobzar, G.; Mardla, V.; Samel, N. (2004). Combined effect of prostaglandins with alpha-tocopherol and quercetin. Platelets, 15 (8), 496.
5.2.
2003
Kobzar, G.; Mardla, V.; Rätsep, I.; Samel, N. (2003). Comparison of platelet aggregation in venous and arterial blood. Journal of Thrombosis and Haemostasis, 1, CD077.
1.1.
2002
Kobzar, G.; Mardla, V (2002). Inhibition of platelet aggregation by pyridoxine. Nutrition Research, 22 (9), 997−1001.
5.2.
2002
Kobzar, G.; Mardla, V.; Rätsep, I.; Raukas, R.; Samel, N. (2002). Inhibition of platelet aggregation by alpha-tocopherol in healthy subjects and patients with coronary artery disease. Platelets, 13 (Abstracts of Papers Presented at the Nottingham Pl), 343.
1.1.
2001
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N (2001). Comparison of anti-aggregatory effects of PGI(2), PGI(3) and iloprost on human and rabbit platelets. Cellular Physiology and Biochemistry, 11 (5), 279−284.
1.2.
2001
Mardla, V.; Kobzar, G.; Rätsep, I.; Lõhmus, M.; Järving, I.; Samel, N. (2001). Sensitivity of platelets to prostaglandins in patients with coronary artery disease. Proceedings of the Estonian Academy of Sciences. Biology. Ecology, 50 (1), 33−36.
1.1.
1999
Kobzar, G.; Mardla, V.; Ratsep, I (1999). Aspirin increases platelet sensitivity to adenosine diphosphate in patients with coronary artery disease. Platelets, 10, 191−192.
1.2.
1999
Kobzar, G.i; Mardla, V.; Rätsep, I. (1999). Sensitivity of platelets to PAF in patients with coronary artery disease. Medical & Biological Engineering & Computing, 37 (1), 242−243.
1.2.
1999
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N. (1999). Blood plasma antiaggregatory potency of prostaglandins: effects of albumin. Inflammopharmacology, 7 (2), 179−185.
5.2.
1998
Kobzar, G.; Mardla, V. (1998). Homocycline effects on platelets. Platelets, 9 (6), 413. DOI: 10.1080/09537109876483.
1.1.
1997
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N.; Lõhmus, M. (1997). Modulatory effect of 8-iso PGE2 on platelets. General Pharmacology, 28, 317−321.
1.1.
1995
Kobzar, G.; Mardla, V.; Järving, I.; Samel, N.; Lõhmus, M. (1995). Effects of 8-iso-PGE2 on platelets and smooth muscles. , 1995, 76, Supplement III, 34. Pharmacology & Toxicology, 76, 34−34.
1.1.
1995
Kobzar, G.; Mardla, V.; Kanger, T.; Lopp, M.; Lille, Ü. (1995). Comparison of the anti-aggregatory activity of enantiomers of a 15-nonstereogenic carbacyclin analogue MM706. Pharmacology & Toxicology, 76, 297−298.
1.1.
1994
Kobzar, Gennadi; Shelkovnikov, Stanislav; Mardla, Vilja; Savitski, Gennadi; Lopp, Margus; Kanger, Tõnis; Lille, Ülo (1994). A 15-nonstereogenic carbocyclic analogue of prostacyclin : effects on human platelets and uterine artery. Journal of lipid mediators and cell signalling, 243−249.
1.1.
1993
Kobzar, G.; Mardla, V.; Järving, I.; Lõhmus, M; Vahemets, A.; Samel, N.; Lille, Ü. (1993). Comparison of the inhibitory effect of E-prostaglandins in human and rabbit platelet-rich plasma and washed platelets. ., 1993, 106C, 489-494. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 106 (2), 489−494. DOI: 10.1016/0742-8413(93)90168-K.
1.1.
1992
Kanger, T.; Lopp, M.; Müraus A., Lõhmus, M.; Kobzar, G.; Pehk, T.; Lille, Ü. (1992). Synthesis of a novel optically active 15-nonstereogenic carbaprostacyclin. Synthesis, 10, 925−927.
1.1.
1992
Lopp, M.; Kobzar, G.; Bergmann, N.; Pehk, T.; Lopp, A.; Valimae, T.; Viigimaa, M.; Lille, U. (1992). Synthesis and antiaggregative activity of novel omega-achiral carba-analogs of prostacyclin. European Journal of Medicinal Chemistry, 27 (2), 155−159.
1.2.
1987
Samel, N.; Järving, I.; Lõhmus, M.; Lopp, A.; Kobzar, G.; Sadovskaya, V.; Välimäe, T.; Lille, Ü. . (1987). Identification and biological activity of a novel natural prostaglandin, 5,6-dihydro-prostaglandin-E3. Prostaglandins, 33 (1), 137−149. DOI: 10.1016/0090-6980(87)90311-X.
20.04.2020

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Lihtotsing Tühjenda
  • Leitud 5 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
SFSF0140010s08Bioaktiivsed lipiidid - metabolism, signaaliülekanne ja regulatsioon01.01.200831.12.2013Nigulas SamelTallinna Tehnikaülikool, Matemaatika-loodusteaduskond893 128,26 EUR
IUTIUT19-9Lipiidide ja lipoproteiinide metabolismi struktuursed ja regulatoorsed aspektid01.01.201431.12.2019Nigulas SamelTallinna Tehnikaülikool, Matemaatika-loodusteaduskond; Tallinna Tehnikaülikool, Loodusteaduskond, Keemia ja biotehnoloogia instituut1 182 000,00 EUR
MUUG3736 (ETF3736)Mõnede vitamiinide ja toidulisandite antiagregatiivne toime vereliistakutele01.01.199931.12.2002Gennadi KobzarTallinna Tehnikaülikool; Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Keemiainstituut, Bioorgaanilise keemia õppetool9 267,19 EUR
MUUT314 (0350314s98)Rasvhapete dioksügenaasid ja eikosanoid-hormoonid01.01.199831.12.2002Nigulas SamelTallinna Tehnikaülikool; Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Keemiainstituut, Bioorgaanilise keemia õppetool93 311,01 EUR
SFSF0142499s03Rasvhappe dioksügenaasid ja eikosanoidhormoonid01.01.200331.12.2007Nigulas SamelTallinna Tehnikaülikool, Matemaatika-loodusteaduskond424 245,52 EUR